Inission (INISS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Q3 2024 sales declined 9.1% year-over-year to SEK 468 million; organic sales fell 16%, with AXXE contributing 33 MSEK.
EBIT for Q3 was SEK 25.8 million (down from 44.3 million), with EPS at 0.6 SEK (1.4 SEK last year).
Cost reduction initiatives are ongoing, with significant cuts in personnel and operational expenses, especially in the Tunis factory.
Order book is down nearly 30% year-over-year, but order intake increased by 6 MSEK to 464 MSEK and duration has normalized.
Inventory value reduced by 29 MSEK in the quarter and by 130 MSEK since Q3 last year (excluding AXXE).
Financial highlights
Net sales for Q3 were 468 MSEK (515 MSEK), and for Jan–Sep 1,619 MSEK (1,642 MSEK).
Net added value (sales minus material) was SEK 9 million higher year-over-year, but SEK 6 million lower when adjusted for AXXE.
EBITDA margin for the quarter in EMS business area was 6.3%; group EBITDA margin was 10.5%.
Cash flow from operations for Q3 was -39.5 MSEK (7.8 MSEK); for Jan–Sep, -62.5 MSEK (68.9 MSEK), impacted by ending factoring and invoicing sales.
Net debt at period end was -526 MSEK (-538 MSEK), with equity ratio at 37.8% (36.2%).
Outlook and guidance
Full-year 2024 sales target revised to SEK 2.1–2.2 billion (from SEK 2.4 billion); EBITDA/EBITA margin expected above 6% (previously 7%).
Management expects downturn to bottom out in Q4, with growth resuming in H2 2025.
Cost base adjustments to be fully realized by Q2 2025.
Mid-term targets remain: 15% annual growth and 9% EBITDA margin.
Slow but steady demand recovery observed, with some factories hiring again.
Latest events from Inission
- Sales and margins rose strongly, with robust order intake and a positive outlook.INISS
Q2 2026 - Q1 2026 saw strong sales, margin growth, and robust order intake, signaling market recovery.INISS
Q1 2026 - 2025 revenue rose to SEK 2,206.2 million, with strong cash flow and a positive 2026 outlook.INISS
Q4 2025 - Sales fell 6.2%, but order intake, cash flow, and acquisitions signal H2 recovery.INISS
Q2 2025 - Revised targets and integration efforts position the company for renewed growth next year.INISS
ABGSC Investor Days - Q2 sales up 1.4% to 570 MSEK, but organic growth and margins declined.INISS
Q2 2024 - Targeting 15% annual growth and 9% EBITDA margin, leveraging acquisitions and mega trends.INISS
CMD 2025 - Order intake up, but sales and margins fell; cost cuts and Nasdaq listing support cautious optimism.INISS
Q1 & AGM 2025 - Sales and margins fell, but order intake and cash flow rebounded; cost cuts and recovery expected.INISS
Q4 2024